COMPUMEDICS LIMITED — Regulatory Filings 2016

Mar 3, 2016

==> picture [74 x 76] intentionally omitted <==

ASX Announcement 4[th] March 2016

Australian Financial Review Article

Compumedics Limited (ASX: CMP) provides the following statement in relation to todays article in the Australian Financial Review (AFR), which referred to Compumedics and its business in China.

Compumedics has relationships with a number of key distributors in China. These distributors all use sub-distributors in various provinces in China.

Compumedics is not connected with the Company referred to in the AFR article. The Company is not known to Compumedics, nor authorized in any way by Compumedics.

Once again we reiterate, Compumedics has no knowledge or involvement in the alleged issue.

Naturally we will undertake our own investigation and review our own policies in order to determine if there is anything further we can do, from our own corporate governance perspective, to avoid issues of this nature arising in the future.

Compumedics has been in business for almost 30 years, the last 16 of which have been as a public company listed on the Australian Stock Exchange, and has an exemplary record when it comes to corporate governance and regulatory compliance, both in Australia and the international countries it does business in.

==> picture [74 x 76] intentionally omitted <==

About Compumedics Limited

Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. The Company owns US based Neuroscan and Germany based DWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovator by both German and Australian Governments.

For further background please visit: www.compumedics.com

For further information please contact:

Dr David Burton , Executive Chairman, CEO Mr David Lawson , Executive Director, CFO Compumedics Limited Compumedics Limited T: + 61 3 8420 7300 T: + 61 3 8420 7300 F: +61 3 8420 7399

For investor relations and media enquiries please contact:

Rod North , Managing Director, Bourse Communications Pty Ltd T: (03) 9510 8309, M: 0408 670 706 E: rod@boursecommunications.com.au